Early adult to midlife cardiovascular risk factors and cognitive function

Circulation

Volumn 129, Issue 15, 2014, Pages 1560-1567

  Yaffe, Kristine ^a,b,c   Vittinghoff, Eric ^a   Pletcher, Mark J ^a,b   Hoang, Tina D ^d   Launer, Lenore J ^e   Whitmer, Rachel ^f   Coker, Laura H ^g   Sidney, Stephen ^f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

^f DIVISION OF RESEARCH   (United States)

^g WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

blood pressure; cholesterol; cognition; glucose; risk factors

Indexed keywords

CHOLESTEROL; GLUCOSE;

ADULT; ADULTHOOD; AGE DISTRIBUTION; ARTICLE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ASSESSMENT TOOL; COGNITION; DIASTOLIC BLOOD PRESSURE; DIET RESTRICTION; DIGIT SUBSTITUTION TEST; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; LEARNING; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RACE DIFFERENCE; REY AUDITORY VERBAL LEARNING TEST; SEX DIFFERENCE; STROOP TEST; SYSTOLIC BLOOD PRESSURE; YOUNG ADULT;

BLOOD PRESSURE; CHOLESTEROL; COGNITION; GLUCOSE; RISK FACTORS;

ADOLESCENT; ADULT; AGE DISTRIBUTION; BLOOD GLUCOSE; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHOLESTEROL; COGNITION; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; NEUROPSYCHOLOGICAL TESTS; PERIPHERAL ARTERIAL DISEASE; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RISK FACTORS; STROKE; YOUNG ADULT;

EID: 84899108433     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.113.004798     Document Type: Article

References (50)

1. Juonala M, Magnussen CG, Venn A, Dwyer T, Burns TL, Davis PH, Chen W, Srinivasan SR, Daniels SR, Kähönen M, Laitinen T, Taittonen L, Berenson GS, Viikari JSA, Raitakari OT. Infuence of age on associations between childhood risk factors and carotid intima-media thickness in adulthood/clinical perspective. Circulation. 2010;122:2514-2520.
2. Gray L, Lee IM, Sesso HD, Batty GD. Blood pressure in early adulthood, hypertension in middle age, and future cardiovascular disease mortality: HAHS (Harvard Alumni Health Study). J Am Coll Cardiol. 2011;58:2396-2403.
3. Pletcher MJ, Bibbins-Domingo K, Lewis CE, Wei GS, Sidney S, Carr JJ, Vittinghoff E, McCulloch CE, Hulley SB. Prehypertension during young adulthood and coronary calcium later in life. Ann Intern Med. 2008;149:91-99.
4. Pletcher MJ, Bibbins-Domingo K, Liu K, Sidney S, Lin F, Vittinghoff E, Hulley SB. Nonoptimal lipids commonly present in young adults and coronary calcium later in life: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Ann Intern Med. 2010;153:137-146.
5. Tolppanen AM, Solomon A, Soininen H, Kivipelto M. Midlife vascular risk factors and Alzheimer's disease: evidence from epidemiological studies. J Alzheimers Dis. 2012;32:531-540.
6. Kivipelto M, Helkala EL, Laakso MP, Hänninen T, Hallikainen M, Alhainen K, Soininen H, Tuomilehto J, Nissinen A. Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study. BMJ. 2001;322:1447-1451.
7. Whitmer RA, Sidney S, Selby J, Johnston SC, Yaffe K. Midlife cardiovascular risk factors and risk of dementia in late life. Neurology. 2005;64:277-281.
8. Shepardson NE, Shankar GM, Selkoe DJ. Cholesterol level and statin use in Alzheimer disease, II: review of human trials and recommendations. Arch Neurol. 2011;68:1385-1392.
9. Staessen JA, Thijs L, Richart T, Odili AN, Birkenhäger WH. Placebo-controlled trials of blood pressure-lowering therapies for primary prevention of dementia. Hypertension. 2011;57:e6-e7.
10. Morris JK, Burns JM. Insulin: an emerging treatment for Alzheimer's disease dementia? Curr Neurol Neurosci Rep. 2012;12:520-527.
11. Joas E, Bäckman K, Gustafson D, Ostling S, Waern M, Guo X, Skoog I. Blood pressure trajectories from midlife to late life in relation to dementia in women followed for 37 years. Hypertension. 2012;59:796-801.
12. Mielke MM, Zandi PP, Shao H, Waern M, Östling S, Guo X, Björkelund C, Lissner L, Skoog I, Gustafson DR. The 32-year relationship between cholesterol and dementia from midlife to late life. Neurology. 2010;75:1888-1895.
13. Reijmer YD, van den Berg E, Dekker JM, Nijpels G, Stehouwer CD, Kappelle LJ, Biessels GJ. Development of vascular risk factors over 15 years in relation to cognition: the Hoorn Study. J Am Geriatr Soc. 2012;60:1426-1433.
14. Jack CR Jr, Knopman DS, Jagust WJ, Shaw LM, Aisen PS, Weiner MW, Petersen RC, Trojanowski JQ. Hypothetical model of dynamic biomarkers of the Alzheimer's pathological cascade. Lancet Neurol. 2010;9:119-128.
15. Kushnick MR, Panton LB. Lipid and lipoprotein concentrations in Americans: ethnicity and age. In: Moffatt RJ, Stamford B, eds. Lipid Metabolism and Health. Boca Raton, FL: CRC Press; 2006:315.
16. Whincup PH, Cook DG, Geleijnse JM. A life course approach to blood pressure. In: Kuh D, Ben-Shlomo Y, eds. A Life Course Approach to Chronic Disease Epidemiology. New York, NY: Oxford University Press; 2004.
17. Hughes GH, Cutter G, Donahue R, Friedman GD, Hulley S, Hunkeler E, Jacobs DR Jr, Liu K, Orden S, Pirie P. Recruitment in the Coronary Artery Disease Risk Development in Young Adults (CARDIA) Study. Control Clin Trials. 1987;8(suppl):68S-73S.
18. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs DR Jr, Liu K, Savage PJ. CARDIA: study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol. 1988;41:1105-1116.
19. Bild DE, Jacobs DR, Liu K, Williams OD, Hilner JE, Perkins LL, Marcovina SM, Hulley SB. Seven-year trends in plasma low-density-lipoprotein-cholesterol in young adults: the CARDIA Study. Ann Epidemiol. 1996;6:235-245.
20. Wechsler D. Wechsler Adult Intelligence Scale-III (WAIS-III). San Antonio, TX: Psychological Corporation; 1997.
21. Stroop JR. Studies of interference in serial verbal reactions. J Exp Psychol. 1935;18:643.
22. MacLeod CM. Half a century of research on the Stroop effect: an integra-tive review. Psychol Bull. 1991;109:163-203.
23. Rosenberg SJ, Ryan JJ, Priftera A. Rey Auditory-Verbal Learning Test performance of patients with and without memory impairment. J Clin Psychol. 1984;40:785-787.
24. Schmidt M. Rey Auditory Verbal Learning Test: A Handbook. Los Angeles, CA: Western Psychological Services; 1996.
25. Lloyd-Jones DM, Hong Y, Labarthe D, Mozaffarian D, Appel LJ, Van Horn L, Greenlund K, Daniels S, Nichol G, Tomaselli GF, Arnett DK, Fonarow GC, Ho PM, Lauer MS, Masoudi FA, Robertson RM, Roger V, Schwamm LH, Sorlie P, Yancy CW, Rosamond WD; American Heart Association Strategic Planning Task Force, Statistics Committee. Defning and setting national goals for cardiovascular health promotion and disease reduction. Circulation. 2010;121:586-613.
26. Carmelli D, Swan GE, Reed T, Miller B, Wolf PA, Jarvik GP, Schellenberg GD. Midlife cardiovascular risk factors, ApoE, and cognitive decline in elderly male twins. Neurology. 1998;50:1580-1585.
27. Elias MF, D'Agostino RB, Elias PK, Wolf PA. Neuropsychological test performance, cognitive functioning, blood pressure, and age: the Framingham Heart Study. Exp Aging Res. 1995;21:369-391.
28. Xu W, Qiu C, Gatz M, Pedersen NL, Johansson B, Fratiglioni L. Mid-and late-life diabetes in relation to the risk of dementia: a population-based twin study. Diabetes. 2009;58:71-77.
29. Solomon A, Kareholt I, Ngandu T, Winblad B, Nissinen A, Tuomilehto J, Soininen H, Kivipelto M. Serum cholesterol changes after midlife and late-life cognition. Neurology. 2007;68:751-756.
30. Stewart R, Xue QL, Masaki K, Petrovitch H, Ross GW, White LR, Launer LJ. Change in blood pressure and incident dementia. Hypertension. 2009;54:233-240.
31. Vuorinen M, Solomon A, Rovio S, Nieminen L, Kåreholt I, Tuomilehto J, Soininen H, Kivipelto M. Changes in vascular risk factors from midlife to late life and white matter lesions: a 20-year follow-up study. Dement Geriatr Cogn Disord. 2011;31:119-125.
32. Knopman DS, Penman AD, Catellier DJ, Coker LH, Shibata DK, Sharrett AR, Mosley TH Jr. Vascular risk factors and longitudinal changes on brain MRI: the ARIC study. Neurology. 2011;76:1879-1885.
33. Debette S, Seshadri S, Beiser A, Au R, Himali JJ, Palumbo C, Wolf PA, DeCarli C. Midlife vascular risk factor exposure accelerates structural brain aging and cognitive decline. Neurology. 2011;77:461-468.
34. Kalaria RN. Vascular basis for brain degeneration: faltering controls and risk factors for dementia. Nutr Rev. 2010;68(suppl):S74-S87.
35. Nishtala A, Preis SR, Beiser A, Devine S, Hankee L, Seshadri S, Wolf PA, Au R. Midlife cardiovascular risk impacts executive function: Framingham Offspring Study [published online ahead of print August 29, 2013]. Alzheimer Dis Assoc Disord. doi: 10.1097/WAD.0b013e3182a715bc. http://journals.lww.com/ alzheimerjournal/pages/articleviewer.aspx?year=9000&i ssue= 00000&article=99676&type=abstract. Accessed November 19, 2013.
36. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI, Tylavsky FA, Newman AB. The metabolic syndrome, infammation, and risk of cognitive decline. JAMA. 2004;292:2237-2242.
37. Yaffe K, Lindquist K, Schwartz AV, Vitartas C, Vittinghoff E, Satterfeld S, Simonsick EM, Launer L, Rosano C, Cauley JA, Harris T. Advanced glycation end product level, diabetes, and accelerated cognitive aging. Neurology. 2011;77:1351-1356.
38. van den Kommer TN, Dik MG, Comijs HC, Jonker C, Deeg DJH. The role of lipoproteins and infammation in cognitive decline: do they interact? Neurobiol Aging. 2012;33:196.e1-196.e12.
39. Lesser GT, Beeri MS, Schmeidler J, Purohit DP, Haroutunian V. Cholesterol and LDL relate to neuritic plaques and to APOE4 presence but not to neurofbrillary tangles. Curr Alzheimer Res. 2011;8:303-312.
40. Knopman DS, Roberts R. Vascular risk factors: imaging and neuropatho-logic correlates. J Alzheimers Dis. 2010;20:699-709.
41. Reed BR, Marchant NL, Jagust WJ, DeCarli CC, Mack W, Chui HC. Coronary risk correlates with cerebral amyloid deposition. Neurobiol Aging. 2012;33:1979-1987.
42. Iadecola C. The overlap between neurodegenerative and vascular factors in the pathogenesis of dementia. Acta Neuropathol. 2010;120:287-296.
43. van Norden AG, van Dijk EJ, de Laat KF, Scheltens P, Olderikkert MG, de Leeuw FE. Dementia: Alzheimer pathology and vascular factors: from mutually exclusive to interaction. Biochim Biophys Acta. 2012;1822:340-349.
44. Raz N, Rodrigue KM, Kennedy KM, Land S. Genetic and vascular modi-fers of age-sensitive cognitive skills: effects of COMT, BDNF, ApoE, and hypertension. Neuropsychology. 2009;23:105-116.
45. Bender AR, Raz N. Age-related differences in episodic memory: a syn-ergistic contribution of genetic and physiological vascular risk factors. Neuropsychology. 2012;26:442-450.
46. Greenwood PM, Lambert C, Sunderland T, Parasuraman R. Effects of apoli-poprotein E genotype on spatial attention, working memory, and their interaction in healthy, middle-aged adults: results from the National Institute of Mental Health's BIOCARD study. Neuropsychology. 2005;19:199-211.
47. Sacco RL. Achieving ideal cardiovascular and brain health: opportunity amid crisis. Circulation. 2011;123:2653-2657.
48. Reis JP, Loria CM, Launer LJ, Sidney S, Liu K, Jacobs DR Jr, Zhu N, Lloyd-Jones DM, He K, Yaffe K. Cardiovascular health through young adulthood and cognitive functioning in midlife. Ann Neurol. 2013;73:170-179.
49. Middleton LE, Yaffe K. Promising strategies for the prevention of dementia. Arch Neurol. 2009;66:1210-1215.
50. Barnes DE, Yaffe K. The projected effect of risk factor reduction on Alzheimer's disease prevalence. Lancet Neurol. 2011;10:819-828.